In individuals with cystic fibrosis (CF), colonization with methicillin-resistant Staphylococcus aureus (MRSA) was reported to be associated with a deterioration of pulmonary disease as reflected by an accelerated decline in lung function. Thus, an early eradication of MRSA could be beneficial in these patients. Here, we report on an intensified MRSA eradication protocol.
Since 2012 a protocol for the eradication of newly acquired MRSA has been used in our CF Clinic, combining oral rifampicin and fusidic acid, inhaled vancomycin, nasal mupirocin, local antiseptic treatment and hygienic directives all of which are applied for only 7 days during an inpatient hospital stay.
Since 2012 seven patients (3 male, 4 female; age range 4 to 30 years) newly acquired MRSA. In 6 of the 7 patients (86%) successful eradication of MRSA was achieved upon first treatment using the protocol described above. In one patient a second course of treatment was performed which, however, also failed to eliminate the colonizing MRSA.
Our protocol led to an eradication rate of 86%. The impact of each individual component of the protocol remains to be determined.
Hall H, Gadhok R, Alshafi K, Bilton D, Simmonds NJ. Eradication of respiratory tract MRSA at a large adult cystic fibrosis centre. Respir Med. 2015;109(3):357–63. https://doi.org/10.1016/j.rmed.2015.01.013. CrossRefPubMed
Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, et al. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus Aureus, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc. 2014;11(7):1120–9. https://doi.org/10.1513/AnnalsATS.201402-050AS. CrossRefPubMedPubMedCentral
Dasenbrook EC. Update on methicillin-resistant Staphylococcus Aureus in cystic fibrosis. Curr Opin Pulm Med. 2011;17(6):437–41. https://doi.org/10.1097/MCP.0b013e32834b95ed. PubMed
Harik NS, Com G, Tang X, Melguizo Castro M, Stemper ME, Carroll JL. Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus Aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence. Am J Infect Control. 2016;44(4):409–15. https://doi.org/10.1016/j.ajic.2015.10.015. CrossRefPubMed
Lo DK, Hurley MN, Muhlebach MS, Smyth AR. Interventions for the eradication of meticillin-resistant Staphylococcus Aureus (MRSA) in people with cystic fibrosis. Cochrane Database Syst Rev. 2015;2:CD009650. https://doi.org/10.1002/14651858.CD009650.pub3.
Goss CH, Muhlebach MS. Review: Staphylococcus Aureus and MRSA in cystic fibrosis. J Cyst Fibros. 2011;10(5):298–306. https://doi.org/10.1016/j.jcf.2011.06.002. CrossRefPubMed
Muhlebach MS, Beckett V, Popowitch E, Miller MB, Baines A, Mayer-Hamblett M, et al. Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial. Thorax. 2017;72(4):318–26. https://doi.org/10.1136/thoraxjnl-2016-208949.
Kappler M, Nagel F, Feilcke M, Kroner C, Pawlita I, Naehrig S, et al. Eradication of methicillin resistant Staphylococcus Aureus detected for the first time in cystic fibrosis: a single center observational study. Pediatr Pulmonol. 2016; https://doi.org/10.1002/ppul.23519.
- Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme
Volker O. Melichar
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II